drugset / Trial / NCT02014402

Safety and Efficacy of Topical Thrombin (Human) Grifols as an Adjunct to Hemostasis During Surgery

NCT02014402

Phase 2 Completed 181 enrolled Grifols, S.A.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This purpose of this clinical trial was to study the safety and efficacy of Topical Thrombin (Human) Grifols as an add-on treatment to help stop bleeding during vascular, liver, soft tissue, and spinal surgical procedures.

Timeline

Start
2013-12
Primary completion
2015-11
Completion
2015-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Bovine Thrombin Protein / enzyme biologic Topical
Subject Human Thrombin Protein / enzyme biologic Topical